ArticleJournal of molecular neuroscience : MN2022

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients.

Yulong Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.